Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Gains from Investment Securities (2019 - 2021)

Historic Gains from Investment Securities for Benitec Biopharma (BNTC) over the last 2 years, with Q3 2021 value amounting to $794000.0.

  • Benitec Biopharma's Gains from Investment Securities changed N/A to $794000.0 in Q3 2021 from the same period last year, while for Jun 2022 it was $794000.0, marking a year-over-year change of. This contributed to the annual value of $794000.0 for FY2022, which is N/A changed from last year.
  • As of Q3 2021, Benitec Biopharma's Gains from Investment Securities stood at $794000.0.
  • In the past 5 years, Benitec Biopharma's Gains from Investment Securities registered a high of $794000.0 during Q3 2021, and its lowest value of $579000.0 during Q3 2019.